Fact Checked

SurvivorNet Fact Checking and Medical Review Standards:  

The SurvivorNet News Team creates high quality medical information that complies with our industry leading standards for factual accuracy and sourcing from leading experts at academic medical institutions. Every news article is thoroughly fact-checked by our physician collaborators. We vet each piece of work for factual integrity, impartiality, and clearly label any professional conflicts.

All SurvivorNet articles adhere to the following standards:

  1. All studies and research papers cited are from reputable academic medical institutions or peer-reviewed journals.
  2. When we use data, statistics, or quotes these references link to the original source.
  3. All content related to new treatments, drugs, procedures, and so on must clearly describe availability, side effects, treatment target (such as triple negative breast cancer)
  4. All medical information on SurvivorNet is sourced from respected medical professionals with verified medical credentials and links are provided to these sources.
  5. We strive to give the reader relevant background information and include, clearly-sourced contextual health information in all articles
6) Readers are clearly alerted to any conflicts of interest from a medical source or the authors of a cited study.
/ Updated April 3rd, 2020

Acute Myeloid Leukemia (AML): Treatment Options After Relapse

NOW
PLAYING
For AML Relapse: The Role of IDH-Inhibitor Drugs To Achieve Remission For Stem-Cell Transplant
NOW
PLAYING
Symptoms of Relapse in Acute Myeloid Leukemia (AML)
NOW
PLAYING
What is The Treatment For Acute Myeloid Leukemia (AML) Patients After Relapse: Gilteritinib And FLT3 Inhibitors
NOW
PLAYING
What Are The Options For Patients When Acute Myeloid Leukemia Returns?

SurvivorNetTV.
Hope. Science.
Inspiration.

Discover SNTV

Relapse : Symptoms & Diagnosis

SEE MORE   

  • Relapse is a part of the journey for many AML patients
  • The timing of relapse will be a big part of making treatment decisions
  • Monitoring health after initial treatment is crucial for people with AML

Relapse : Symptoms & Diagnosis

  • Relapse is a part of the journey for many AML patients
  • The timing of relapse will be a big part of making treatment decisions
  • Monitoring health after initial treatment is crucial for people with AML

Relapse : Exploring the Options

SEE MORE   

  • Drugs such as Ivosidenib or Enasidenib can be given to help achieve remission in patients with relapsed AML
  • Recently approved drugs, like FLT3-inhibitor Gilteritinib, have also shown great promise in treating relapsed disease

Relapse : Exploring the Options

  • Drugs such as Ivosidenib or Enasidenib can be given to help achieve remission in patients with relapsed AML
  • Recently approved drugs, like FLT3-inhibitor Gilteritinib, have also shown great promise in treating relapsed disease
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.